Intercell’s needle-free patch delivery technology has the potential to change the way vaccines are delivered, according to Jean Stephenne, president of GSK Biologicals.
More than 50 per cent of executives believe their company fails to respond quickly enough to pandemics because of lapses in the supply chain, according to an IBM survey.
Sinovac’s recently opened vaccine filling and packaging facility in Beijing, China has received SFDA GMP certification, which the firm says will increase production capacity to around 40m doses a year.
Sanofi-Aventis' H5N1 bird flu vaccine has won approval from the US
Food and Drug Administration (FDA) as a limited protection measure
in case of a pandemic.
Pharmaceutical companies manufacturing vaccines to protect against
avian flu outbreaks will be protected from product liability claims
according to new regulations announced by the US Department of
Health and Human Services (HHS).
Drug giant GlaxoSmithKline (GSK) has been awarded a contract with
the US government to supply 800,000 doses of flu vaccine to the US,
where a bird flu pandemic still remains a threat.
Responding to surging demand for its flu drug Tamiflu, Roche has
announced it is expanding its external contractors to fifteen in
nine different countries, as its needs for intermediates and
finished product increase.
Concern over the threat of a new flu pandemic is hiking demand for
Roche's Tamiflu >(oseltamivir phosphate) product to the extent
that the firm needs to build another production plant, reports
Phil Taylor.
